Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

FDA approves Valeant’s psoriasis treatment

Thursday, February 16, 2017 9:11
% of readers think this story is Fact. Add your two cents.

The US Food and Drug Administration (FDA) has approved Valeant Pharmaceuticals Inc’s (NYSE:VRX) Siliq to treat adults with moderate-to-severe plaque psoriasis.

Plaque psoriasis – the most common form of the autoimmune disorder psoriasis – causes sufferers to develop thick, red skin with flaky, white scales.

In the clinical trials, patients treated with Siliq had shown suicidal behaviour, the FDA said.

The approval for the injection includes a labelling with boxed warning to mitigate the risks of suicide.

Shares were down 3%, or US$0.53, to US$16.28.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.